NEWS

NEWS

The Successful Opening of the Fourth Tuberculosis R&D Cooperation International Forum

2024-03-05

5th March, 2024, Xiamen 2-3rd March, the fourth TB R&D cooperation international forum was successfully held in Xiamen, Fujian province. This forum has been a collaboration between the Innovation Alliance (IATB) and the Bill & Melinda Gates Foundation (BMGF) with the latter providing technical assistance and philanthropic donations. The past three forums addressed issues of pre-clinical ...
Successful Opening of the First Seminar on Tuberculosis International Public Health Market Development by China’s Innovative Diagnostic Companies

2024-03-03

3rd March, 2024, XiamenNight 2nd March, Xiamen. The First Seminar on Tuberculosis International Public Health Market Development by China’s Innovative Diagnostic Companies was successfully held. This seminar was a collaboration between the Innovation Alliance (IATB) and Bill & Melinda Gates Foundation (BMGF) with the latter providing technical assistance and philanthropical donations. The a...
Muti-disease Radiological Screening Project successfully kicked off in Dongfang city, Hainan Province

2024-08-01

1st August, 2024, Dongfang, HainanIn responding to the call of improving life expectancy through reduction of tuberculosis and lung cancer burden. Organized and implemented by the Innovation Alliance (IATB). The first national multi-disease radiological screening project was kick off in Dongfang city, Hainan province. More than 23,500 at-risk local population will be given free of charge screeni...
Beijing Chest Hospital is to Lead a National Multi-Center Prospective Randomized Clinical Trial

2024-06-01

1th June, 2024, Beijing Multi drug and rifampicin resistant tuberculosis (MDR/RR-TB) still represents a serious threat to global public health. Treatment success rate of traditional long course regimen (≥18 month) for this disease lingers below 60%. While short course all oral Bedaquiline containing regimens currently recommended by the WHO, such as BPaL and BPaLM are not yet accessible for Chi...
First 1 2 3 4 5 6 7 8 9 > Last